Hip osteoarthritis Hip steroid injection Hip osteoarthritis
Conditions
Interventions
injection of 20 mg triamcinolone acetonide intra-articular of osteoarthritis hip under fluoroscopic controlled,injection of 40 mg triamcinolone acetonide intra-articular of osteoarthritis hip under fl
Experimental Drug,Active Comparator Drug
20mgHI,40mgHI
Sponsors
Thai Orthopedic Society for Sports Medicine (TOSSM)
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. primary and secondary osteoarthritis of hip in Tonnis classification 1-3 with failure conservative treatment more than 4 weeks. (If bilateral involvement, evaluated the main site or injection site) 2. age between 40-80 years 3. no history of previous hip surgery 4. no history of hip injection within 1 year before enrollment 5. understand well in Thai language and can made self-decision
Exclusion criteria
Exclusion criteria: 1. uncontrolled and poor-controlled diabetic mellitus 2. history of infection around the hip joint 3. osteonecrosis of hip 4. Inflammatory hip arthritis such as Ankylosing Spondylitis, Sero-Negative Spondyloarthropathy, rheumatoid arthritis 5. allergy to anesthetic agents or steroid 6. pregnancy (by history taking if LMP) 7. history of degenerative spine disease with significant radicular pain or neurological deficit 8. evidence of osteolytic or osteoblastic lesion around the hip 9. planning for hip replacement within 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EQ5D-VAS 2, 6 , 12, 18, 24 weeks 0-100 scale,HOOS 2, 6 , 12, 18, 24 weeks scale,mHHS score 2, 6 , 12, 18, 24 weeks scale | — |
Secondary
| Measure | Time frame |
|---|---|
| VAS pain 2, 6 , 12, 18, 24 weeks 0-10 scale | — |
Countries
Thailand
Contacts
Public ContactAdinun Apivatgaroon
Thammasat University
Outcome results
None listed